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Leber hereditary optic neuropathy (LHON) is the most extensively studied mitochondrial disease, with the majority of the cases being
caused by one of three primarymitochondrial DNA (mtDNA)mutations. Incomplete disease penetrance and gender bias are two features
of LHON and indicate involvement of additional genetic or environmental factors in the pathogenesis of the disorder. Haplogroups J, K,
and H have been shown to inﬂuence the clinical expression of LHON in subjects harboring primary mutations in European families.
However, whether mtDNA haplogroups would affect the penetrance of LHON in East Asian families has not been evaluated yet. By
studying the penetrance of LHON in 1859 individuals from 182 Chinese families (including one from Cambodia) with the
m.11778G/A mutation, we found that haplogroup M7b102 signiﬁcantly increases the risk of visual loss, whereas M8a has a protective
effect. Analyses of the completemtDNA sequences from LHON families withm.11778G/A narrow the association of disease expression
tom.12811T/C (Y159H) in theNADH dehydrogenase 5 gene (MT-ND5) in haplogroupM7b102 and suggest that the speciﬁc combination
of amino acid changes (A20T-T53I) in the ATP synthase 6 protein (MT-ATP6) caused by m.8584G/A and m.8684C/T might account
for the beneﬁcial background effect of M8a. Protein secondary-structure prediction for the MT-ATP6 with the two M8a-speciﬁc amino
acid changes further supported our inferences. These ﬁndings will assist in further understanding the pathogenesis of LHON and guide
future genetic counseling in East Asian patients with m.11778G/A.Leber hereditary optic neuropathy (LHON, MIM 535000)
is a common cause of acute or subacute visual loss in
young adults, predominately affecting males.1–4 The
prevalence of LHON in western Europe is about one in
25,000–50,000 individuals.1,5,6 Genetic defects in themito-
chondrial DNA (mtDNA) genome play a key role in the
development of LHON, inwhich the three primarymtDNA
mutations (m.11778G/A [R340H] inNADH dehydrogenase
4 gene [MT-ND4, MIM 516003], m.14484T/C [M64V] in
MT-ND6 [MIM 516006], and m.3460G/A [A52T] in
MT-ND1 [MIM 516000]) contribute to about 95% of LHON
cases.1,4,6 However, the phenotypic expression of these
primary mutations is very complex. Only about one-third
of individuals harboring one of these threemutations even-
tually develop LHON, and the penetrance varies among
different families.1,7,8 Therefore, identiﬁcation of other
factors affecting LHON penetrance would be of value in
elucidating the pathophysiology of retinal neuron loss, as
well as in searching for clues that might relieve visual loss
or prevent the onset of LHON. Many factors, such as
mtDNA background, heteroplasmy of mtDNA mutation,
nuclear gene(s), and environmental factors, have been
shown to play active roles in the phenotypic expression of
LHON.1,4,9–20
Most recently,Hudsonet al.7 provided clear evidence that
the expression of LHON primarymutations was inﬂuenced
by the mtDNA haplogroup background in European fami-760 The American Journal of Human Genetics 83, 760–768, Decemblies. The risk of visual failure is higher when m.11778G/
A or m.14484T/C mutations are present in haplogroup J
and when m.3460G/A is present in haplogroup K,
whereas haplogroup H reduces the disease manifestation
in families with m.11778G/A.7 The cause of the associa-
tion of mtDNA background effect (subclades J1 and J2b)
with LHON expression in families with m.11778G/A or
m.14484T/Chas been narrowed to two speciﬁc combina-
tions of amino acid changes (L236I-F19L and L236I-
D171N-V356M) in the cytochrome b gene (MT-CYB; MIM
516020).21 Because the distribution patterns of the three
primary mutations7,8 and the matrilineal genetic struc-
tures22,23 differ remarkably in populations from Europe
and East Asia, it is indispensable to disclose the potential
haplogroup effects on LHON expression in East Asians.
One hundred and seventy-ﬁve families with LHON and
the m.11778G/A mutation were identiﬁed across China
from our routine clinical diagnosis of 1369 unrelated sub-
jects suspected of having LHON (including those families
thatwere described in our previous studies8,24–26). The pres-
ence of the primary mutation m.11778G/A was veriﬁed
by direct sequencing or allele-speciﬁc PCR in all families
in the present study. In all cases, we detected no hetero-
plasmy for the m.11778G/A mutation. The clinical diag-
noseswere determined at the ZhongshanOphthalmic Cen-
ter or by local ophthalmologists. Unaffected individuals
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consent, conforming to the tenets of the Declaration of
Helsinki and following the guidance of sample collection
of Human Genetic Disease (863 program) by the ministry
of Public Health of China, was obtained from participants
prior to this study, whichwas approved by the institutional
review boards of the Zhongshan Ophthalmic Center and
the Kunming Institute of Zoology. We followed the avail-
able approach to assign each mtDNA to its respective
haplogroup, as previously described.23,24,27 In brief, each
sample was analyzed for a 1.4 kb fragment (region 16024-
850) that covers the entiremtDNA control-region sequence
and was classiﬁed on the basis of the recognition of the
haplogroup motif and its matching or near-matching
with reported Chinese mtDNAs.23,27 Coding-region muta-
tion motifs (e.g., m.5178C/A [MT-ND2: L237M; MIM
516001] for haplogroup D, recognized by 5176AluI)
were screened to further solidify the inferred haplogroup
status for some lineages. In addition, LHON penetrance
information of ten reported Chinese families with
m.11778G/A25,26,28–32 was also included for analysis in
this study. Note that there were some errors in seven of
those reported complete mtDNA sequences28–32 and that
we classiﬁed those samples following a well-described strat-
egy.33,34 The completemtDNA sequencewas determined in
probands from seven M7b families, three F families, three
M8a families, and two G families via the same strategy
and ampliﬁcation and sequencing conditions as described
Table 1. Haplogroup Frequency for the 1859 Subjects,
from 182 Pedigrees, with the Primary LHON Mutation
m.11778G/A
Haplogroup
No. of
Subjects (%)a
No. of
Families (%)a
Pooled Han
Chinese (%)b p Valuec
D4 432 (23.24) 43 (23.63) 56 (13.73) 0.004
D5 161 (8.66) 15 (8.24) 27 (6.62) 0.491
B4 197 (10.60) 19 (10.44) 55 (13.48) 0.347
B5 115 (6.19) 10 (5.49) 17 (4.17) 0.523
M7b102 136 (7.32) 15 (8.24) 24 (5.88) 0.370
M7c 122 (6.56) 12 (6.59) 11 (2.70) 0.036
G 139 (7.48) 12 (6.59) 14 (3.43) 0.126
M8a 112 (6.02) 10 (5.49) 18 (4.41) 0.675
M10 113 (6.08) 8 (4.40) 8 (1.96) 0.104
A 75 (4.03) 10 (5.49) 25 (6.13) 0.852
Y 60 (3.23) 6 (3.30) 6 (1.47) 0.203
C 46 (2.47) 7 (3.85) 11 (2.70) 0.605
F 27 (1.45) 4 (2.20) 68 (16.67) 13106
N9a 34 (1.83) 3 (1.65) 15 (3.68) 0.209
M12 35 (1.88) 2 (1.10) 2 (0.49) 0.591
R11 9 (0.48) 2 (1.10) 4 (0.98) 1.000
M9a 8 (0.43) 1 (0.55) 10 (2.45) 0.186
Z 9 (0.48) 1 (0.55) 8 (1.96) 0.287
Other 29 (1.56) 2 (1.10) 29 (7.11) 0.001
Total 1859 182 408 –
a The reported families24–26,28–32 were also included.
b Pooled Han Chinese individuals from Yunnan, Hubei, Xinjiang, Liaoning,
Shandong, and Guangdong Provinces reported by Yao et al.23,39 and Kivisild
et al.37
c Fisher’s exact test (two-tailed) was performed on the basis of the number
of lineages in the pooled Han Chinese and LHON samples.The Americain our recent study.25 Sequence variations were scored rela-
tive to the revised Cambridge reference sequence (rCRS).35
The classiﬁcation tree of the complete mtDNA sequences
was drawn via the same procedure as described in our
previous studies and others.33,36–38
We did not consider the age of subjects as a risk factor for
the disease penetrance and included all subjects, irrespec-
tive of age, in order to avoid an ascertainment bias in
elevating the penetrance value in the pedigree.7 The fol-
lowing family members were excluded from the analysis:
(1) the ﬁrst generation, (2) spouses of the matrilineal mem-
bers, and (3) children of the male member in each family.
In total, we evaluated the penetrance of LHON in 1859
individuals carrying the m.11778G/A mutation, from
182 Chinese families that were located in South and North
China (including one family from Cambodia). Among
these subjects, 50.6% were male and 49.4% were female.
Binary logistic regression was used for determining the
effects of the variables (sex and haplogroup) on the
Table 2. Haplogroup Distribution of Affected and Unaffected
Individuals in 182 Families with the Primary Mutation
m.11778G/A
Sex and Haplogroup
No. of Individuals with G11778A
Affected Unaffected
Male
M7b102 41 27
M7c 25 42
M8a 15 39
C 20 9
M10 30 33
D4 91 129
D5 37 34
A 24 16
B4 44 57
B5 21 32
G 41 26
Y 14 20
F 7 5
Other 26 35
Total 436 504
Female
M7b102 15 53
M7c 9 46
M8a 7 51
C 3 14
M10 10 40
D4 43 169
D5 23 67
A 7 28
B4 20 76
B5 10 52
G 21 51
Y 1 25
F 3 12
Other 11 52
Total 183 736
The previously reported Chinese families with LHON and m.11778G/
A25,26,28–32 were included. For detailed information, refer to Tables S1 and S2.n Journal of Human Genetics 83, 760–768, December 12, 2008 761
Table 3. Effect of Gender and mtDNA Haplogroups on Phenotypic Manifestation of the Primary Mutation m.11778G/A
Variable
All 182 Families 140 Familiesa
p Value Odds Ratio 95% CI p Value Odds Ratio 95% CI
Sex 2.613 3 1032 3.479 2.830–4.277 5.576 3 1027 3.324 2.671–4.138
M7b102 0.032 1.503 1.035–2.183 0.015 1.631 1.100–2.416
M7c 0.101 0.702 0.460–1.071 0.123 0.706 0.454–1.099
M8a 0.002 0.460 0.282–0.751 0.001 0.391 0.224–0.682
C 0.050 1.845 1.000–3.404 0.154 1.655 0.828–3.308
M10 0.861 1.038 0.685–1.571 0.451 1.173 0.775–1.778
D4 0.213 0.858 0.675–1.092 0.151 0.827 0.638–1.071
D5 0.092 1.353 0.952–1.923 0.076 1.394 0.965–2.013
A 0.157 1.426 0.872–2.331 0.154 1.467 0.867–2.481
B4 0.744 0.947 0.682–1.314 0.911 0.981 0.697–1.381
B5 0.204 0.752 0.484–1.167 0.165 0.714 0.443–1.149
G 0.001 1.827 1.266–2.637 0.003 1.825 1.230–2.709
Y 0.091 0.590 0.320–1.088 0.097 0.580 0.305–1.104
Fb 0.530 1.302 0.571–2.966 – – –
Other 0.429 0.847 0.560–1.280 0.705 0.928 0.629–1.368
Statistical testing was performed on the basis of the original data in Table S2. The visual failure was regarded as the dependent variable in the binary
logistic-regression model. The haplogroups (present in at least four families) were separately introduced into the regression equation with the independent
variable sex and the dependent variable visual failure.
a 42 small pedigrees were excluded.
b When the small pedigrees were not considered, haplogroup F was excluded because of the small number of families.phenotypic expression of LHON with the use of SPSS 13.0
(SPSS, Chicago, IL). In regard to sample size and statistical
power, we only considered the haplogroups shared by at
least four families as variables in the statistical analysis.
The remaining haplogroups were aggregated together
into one variable. In total, 14 variables, including hap-
logroups M7b102, M7c, M8a, C, M10, D4, D5, A, B4, B5,
G, Y, F, and others (lumping together Z, M9, M12, N9a,
R11, and U), were separately introduced into the regression
equation, with the independent variable sex and the
dependent variable visual failure. Other potential variables,
such as heteroplasmy of the primary mutation and
pedigree generation, were neglected in our study. A p value
less than 0.05 was regarded as statistically signiﬁcant.
Table 1 andTable S1 (availableonline) list thedistribution
frequencies of mtDNA haplogroups in our cohort of fami-
lies. The overall pattern was similar to the general proﬁle
that was observed in 41 families in our recent study,24
with haplogroups D, B, and M7 being the prevalent
haplogroups. Only four of the 182 families (2.2%) with
m.11778G/A belonged to haplogroup F (including
family WZ4 reported by Qian et al.29); this frequency was
signiﬁcantly lower than the expected frequency, which
ranges from 6%–27% in the regional Chinese populations
across China.23,37,39 However, the overall LHON pene-
trance in these four families ranged from 25%–75% and
was not at a lower rate of penetrance compared to that in
those families with other haplogroup status (Table 2 and
Table S2).We also failed to observe a signiﬁcant haplogroup
effect of F on the penetrance of LHON (p¼ 0.530; odds ratio
[OR] ¼ 1.302; 95% conﬁdence interval [CI] ¼ 0.571–2.966)
in these F families (Table 3). The exact reason for such a low
frequency of F in LHON lineages24 with no effect on pene-
trance remains unclear. Population stratiﬁcation might762 The American Journal of Human Genetics 83, 760–768, Decembaccount for this pattern. When we pooled the published
regional Han Chinese23,37,39 as one population, to mimic
the heterogeneous nature of the LHON population,
haplogroup Fwas still signiﬁcantly lower in the LHONpop-
ulation compared to the aggregated sample (Fisher’s exact
test, two tailed p ¼ 1 3 106). Conversely, the frequencies
of haplogroups D4 and M7c were signiﬁcantly higher (p <
0.05) in the LHON patients compared to the pooled Han
Chinese, but none of them affected the LHON penetrance
(Tables 1 and 3). Analysis of the complete mtDNA
genomes of the four haplogroup F families with LHON
andm.11778G/A failed toprovide anyuseful information
(Figure 1 and Table 4), because these mtDNA samples
belonged to different subbranches (two F1a, one F1b, and
one F2a).
Consistentwith aprevious report for EuropeanLHONpa-
tients,7 sex is also the strongest predictor for visual loss in
Chinese families (p ¼ 2.613 3 1032; OR ¼ 3.479; 95%
CI ¼ 2.830–4.277), with a 3.5-fold increased risk of visual
failure for males compared with females. Haplogroups
M7b102 and G increased the risk of visual failure 1.5-fold
(p ¼ 0.032; OR ¼ 1.503; 95% CI ¼ 1.035–2.183) and 1.8-
fold (p¼ 0.001,OR¼ 1.827, 95%CI¼ 1.266–2.637), respec-
tively.HaplogroupM8awas found tobe associatedwitha re-
duced risk (p¼ 0.002; OR¼ 0.460; 95% CI ¼ 0.282–0.751).
Because some of the pedigrees studied here were relatively
small, we then excluded 42 pedigrees (each having ﬁvema-
ternally related individuals at most) in order to eliminate
the potential bias in scoring the affected and unaffected in-
dividuals in these small pedigrees. Analysis for the residual
1710 subjects from140 families then yielded similar results,
with an increased risk for haplogroups M7b102 (p ¼ 0.015,
OR¼ 1.631, 95%CI¼ 1.100–2.416) andG (p¼ 0.003,OR¼
1.825, 95% CI ¼ 1.230–2.709) and a reduced risk forer 12, 2008
Figure 1. Classification Tree of 20 Complete mtDNAs with m.11778G/A and the Revised Cambridge Reference Sequence
Haplogroup names are inserted along the branches that determine the locations of the corresponding ancestral haplotypes, following the
most recent update of the East Asian mtDNA phylogeny.36 Suffixes ‘‘C’’ and ‘‘A’’ refer to transversions, and ‘‘þ5C’’ signifies an insertion of
five cytosines. Deletion and heteroplasmy of a mutation are indicated by suffixes ‘‘d’’ and ‘‘h,’’ respectively. Back mutations are highlighted
by the prefix ‘‘@,’’ and recurrent mutations are underlined. The synonymous and nonsynonymous coding-region variants in the samples
are further denoted by ‘‘/s’’ and ‘‘/ns,’’ respectively. Nucleotide variations that are located in the tRNA genes and the rRNA genes are
marked with ‘‘/t’’ and ‘‘/r,’’ respectively. Length mutations of the C-tract in region 303–309 and the m.11778G/A mutation in the
20 mtDNAs were omitted from the tree. Sequence WZ4 is taken from Qian et al.29 but obscured by several errors (33). Families Le1244,
Le1269, and Le696 are taken from our recent studies.25,26 The Japanese LHON patient with intracranial arteriovenous malformation
(AVM) is taken from Fujitake et al.40The American Journal of Human Genetics 83, 760–768, December 12, 2008 763
Table 4. Private Nonsynonymous mtDNA Sequence Variations in Chinese Families with LHON and m.11778G/A
Family Haplogroup
Nucleotide Variant
(Amino Acid Change)a Gene
Reported
(Population Context)b
Reported
(Disease Context)b Conservationc
Le699 F1a1 G8839A (A105T) MT-ATP6 yes yes yes
G8545A (A7T) MT-ATP6 yes no no
A8507G (N48D) MT-ATP8 yes no no
T4216C (Y304H) MT-ND1 yes yes no
Le1048 F1b1 G15119A (A125T) MT-CYB yes no yes
G15734A (A330T) MT-CYB yes yes yes
Le924 M7b102 C6228T (L109F) MT-CO1 no no no
Le1127 M7b102 A7158G (I419V) MT-CO1 yes yes no
Le217 M7b1 A13105G (I257V) MT-ND5 yes yes no
Le1174 M7b1 G7444C (X514T) MT-CO1 no no –
C10159T (S34F) MT-ND3 no no no
Le265 M7b1 T10084C (I9T) MT-ND3 yes no no
C10159T (S34F) MT-ND3 no no no
Le266 M8a G3776A (S157N) MT-ND1 no no no
Le1031 M8a2 G15734A (A330T) MT-CYB yes yes yes
Le258 M8a2b T10747A (L93Q)d MT-ND4L no no yes
G14259A (P139S) MT-ND6 yes no no
Le953 G1c G9966A (V254I) MT-CO3 yes yes yes
Le1269 G2a G13708A (A458T) MT-ND5 yes yes no
Le1244 G2a1 G7604A (V7M) MT-CO2 yes no no
a The nucleotide variants were listed in a format for web-based searches, e.g. mutation G8839A should be presented as 8839G/A and m.8839G/A
according to the ‘‘traditional’’ and ‘‘approved’’ formats for mtDNA-mutation nomenclature56, respectively.
b The search was performed on Aug 18, 2008, with the strategy described in Bandelt et al.41 followed (e.g. both ‘‘G8839A mtDNA’’ and ‘‘8839G/A mtDNA’’
were queried).
c The conservation analysis was performed by a comparison of human mtDNA (GenBank accession no. J01415) to eight different vertebrate species,
including zebrafish (NC_002333), frog (AB043889), blue whale (NC_001601), mouse (AY466499), cattle (AY526085), horse (EF597513), dog
(DQ480502), and gorilla (NC_001645).
d This site is heterogeneous for T and A.haplogroup M8a (p ¼ 0.001, OR ¼ 0.391, 95% CI ¼ 0.224–
0.682) (Table 3). To minimize the probability of type II
errors in the above test, we performed logistic regression
by introducing all 14 variables in the regression equation,
with the independent variable sex and the dependent vari-
able visual failure. The increased risk for haplogroups
M7b102 and G and the decreased risk for haplogroup
M8a in phenotypic manifestation of m.11778G/A was
further conﬁrmed (considering all 182 families: M7b102,
p ¼ 0.012, OR ¼ 1.630, 95% CI ¼ 1.116–2.382; G, p ¼
4.59 3 104, OR ¼ 1.949, 95% CI ¼ 1.342–2.832; M8a,
p ¼ 0.013, OR ¼ 0.535, 95% CI ¼ 0.326–0.878; excluding
42 small pedigrees: M7b102, p ¼ 0.008, OR ¼ 1.714, 95%
CI ¼ 1.150–2.554; G, p ¼ 0.002, OR ¼ 1.903, 95% CI ¼
1.275–2.840; M8a, p ¼ 0.005, OR ¼ 0.445, 95% CI ¼
0.254–0.779).
The association between an increased risk of visual loss
and haplogroup G is unexpected, because different fami-
lies belonging to this haplogroup presented strikingly dif-
ferent penetrance patterns.25,26 In particular, one reported
family (Le696)26 had a very high penetrance (78.6%) and
harbored two pathogenic mutations, m.1555A/G
(MT-RNR1; MIM 561000) andm.11778G/A, whichmight
have enhanced the phenotypic expression and caused
a bias in estimation of the haplogroup background effect.
Indeed, when we excluded this family, together with four
small pedigrees from the analysis, haplogroup G did not764 The American Journal of Human Genetics 83, 760–768, Decembsigniﬁcantly increase the penetrance of LHON (p ¼
0.051, OR ¼ 1.526, 95% CI ¼ 0.998–2.335). Therefore,
the effect of haplogroup G on the clinical expression of
LHON should be treated with caution and further veriﬁed
in a future study with more pedigrees. Analysis of the ﬁve
LHON families with G status shows that these mtDNA
samples can be grouped into subhaplogroups G1c, G2a,
and G2b and thus share only one nonsynonymous
haplogroup-speciﬁc variant, viz. m.4833A/G (T122A)
in the MT-ND2 gene (Figure 1), which might account for
the predisposing effect of haplogroup G in LHON pene-
trance.
To further deﬁne the effect of haplogroup M7b102 on
LHON penetrance, we narrowed the potential association
to speciﬁc mtDNA mutations by analyzing the entire
mtDNA genomes of eight M7b102 families (including one
previously reported Japanese LHONprobandwith intracra-
nial arteriovenousmalformation40) (Figure 1). All probands
shared a string of nonsynonymousmutations (m.4048G/
A [D248N] in MT-ND1, m.5460G/A [A331T] in MT-ND2,
and m.7853G/A [V90I] in MT-CO2 [cytochrome c oxidase
II; MIM 516040]) and synonymous variants (m.4164A/G
in MT-ND1, m.5351A/G in MT-ND2, m.6680T/C in
MT-CO1 [MIM 516030], m.7684T/C inMT-CO2) that are
characteristic of haplogroup M7b, as well as m.12811T/
C (Y159H) in MT-ND5 (MIM 516005), which deﬁnes
haplogroup M7b102. At the twig level, we identiﬁed ﬁveer 12, 2008
nonsynonymousmutations in families Le924 (m.6228C/
T [MT-CO1: L109F]), Le1127 (m.7158A/G [MT-CO1:
I419V]), Le1174 (m.7444G/C [MT-CO1: X514F];
m.10159C/T [MT-ND3: S34F; MIM 516002]), and Le217
(m.13105A/G [MT-ND5: I257V]). With the exception of
m.6228C/T, m.7444G/C, and m.10159C/T, all vari-
ants can be found in reportedmtDNA samples via standard
database andweb-based searches.41 Someof the variants are
evolutionarily conserved and have been reported in disease
context (Table 4). None of these mtDNA variants has
been reported to be associated with LHON, except for
m.12811T/C, which was considered to be a secondary
mutation for LHON expression42 and was present in
two out of 35 Finnish LHON probands.5 In addition,
m.12811T/C could be found in three out of 63 Dutch
LHON patients,43 one case individual with cancer,44 and
one patient with cerebral autosomal-dominant arteriopa-
thy with subcortical infarcts and leukoencephalopathy
(MIM 125310),45 according to extensive database searches.
In the non-European context, m.12811T/C was regarded
as a haplogroup-speciﬁc polymorphism in East Asians
(M7b102)36 and Native Americans (A2h).46 The potentially
synergistic effect of m.11778G/A and m.12811T/C
might be the reason for an increased penetrance on the
haplogroup M7b102 background.
Intriguingly, three of the ﬁve M7b102 lineages that har-
bored nonsynonymous mutations at the twig level also
had private amino acid changes in the MT-CO1 gene (Fig-
ure 1 and Table 4); this suggests that the decreased activity
of cytochrome c oxidase and the partial dysfunction of
complex IV might be related to the onset of LHON.9,47–49
For instance, m.7444G/A in the MT-CO1 gene causes
a change of the termination codon of MT-CO1 to lysine
and was claimed to be associated with LHON,47 although
this variant was prevalent in haplogroup V and should be
categorized as a polymorphism.33 Note that a recent study
showed that pathogenic mutations are also common in
the general population.50 The previously unpublished
variant m.7444G/C in Le1174 causes a similar problem
as that of m.7444G/A and results in a change of the
termination codon to threonine. Whether the change of
the mitochondrial respiratory-chain complexes I and IV
activities caused by the above mutations in MT-CO1,
MT-CO2, MT-ND1, MT-ND2, MT-ND3, and MT-ND5 in
M7b102 lineages would account for an increased risk for
LHON awaits further experimental study. It is worth
noting that in a recent study by Kazuno et al.,51 the four
cybrid lines containing mtDNA with haplogroup status
G1a1 (two), M7b2, and M7a1a generally had a lower cyto-
solic calcium response to histamine and a higher-level
mitochondrial matrix pH compared to those cybrids con-
taining mtDNA belonging to haplogroups N9a, A, B4,
etc. This result suggests that potential alterations in mito-
chondrial pH and calcium concentration caused by the
haplogroup background effects of M7b102 and G might
be one of the mechanisms for the increased risk of LHON
penetrance.The AmericanA protective effect of mtDNA haplogroup background
has been reported for several diseases; e.g., haplogroup
N9a confers resistance to type 2 diabetes in Asians52 and
to metabolic syndrome in Japanese women,53 and hap-
logroup H reduces the risk of visual failure in European
families with m.11778G/A.7 In this study, we found
that M8a enacted a protective effect on the disease expres-
sion in Chinese LHON families, and this protective effect
became even more pronounced when we discarded small
pedigrees. Analysis of three complete M8a mtDNA se-
quences from these families showed that each mtDNA
had at least one private nonsynonymous nucleotide
change at the twig level (Figure 1 and Table 4). Family
Le258 had a previously unpublished heterogeneous
mutation at site 10747, and this site was conserved in ver-
tebrates. Intriguingly, the haplogroup-speciﬁc nonsynony-
mous-variant pair m.8584G/A andm.8684C/T, causing
a combination of amino acid changes A20T and T53I, is
located in the ATP synthase 6 gene (MT-ATP6; MIM
516060). We performed protein secondary-structure
modeling for the MT-ATP6 protein harboring the two
M8a-speciﬁc amino acid changes in comparison to mu-
tants containing a well-known pathogenic mutation at
site 8993 (m.8993T/G orm.8993T/C), a rare LHONmu-
tation m.9101T/C,54,55 as well as the wild-type (rCRS) by
using the TMpred program. As shown in Figure 2, MT-ATP6
is a largely hydrophobic protein and contains two hydro-
philic loops. Bothm.8993T/C andm.8993T/Gmutants
alter the hydrophobicity, but m.8993T/G has a stronger
effect, whereas m.9101T/C decreases the hydrophobicity
close to the C-terminal end. The amino acid change A20T
of M8a decreases the hydrophobicity, but this change is
balanced by a reduction of hydrophilicity in the adjacent
region, caused by T53I. It thus seems that the two speciﬁc
amino acid changes are the cause of the protective effect of
M8a and that they enhance the activity of the mitochon-
drial ATP synthase complex. Experimental data will be
essential for conﬁrming this speculation.
In summary, by studying 1859 individuals in 182
Chinese families with LHON andm.11778G/A, we found
that haplogroup M7b102, as well as, possibly, haplogroup
G, signiﬁcantly increased the risk of visual failure in Chi-
nese individuals with m.11778G/A, whereas M8a might
have a protective effect on the penetrance of LHON. Sex
is the most signiﬁcant factor for inﬂuencing the clinical
expression of LHON (3.48-fold) in Chinese families but
this inﬂuence is lower than that in European LHON fam-
ilies (5.41-fold). Haplogroup F is present at a much lower
frequency in these affected families than in the general
Han Chinese when we only counted the matrilines,
whereas haplogroups D4 and M7c are present at a signiﬁ-
cantly higher frequency in the affected families. However,
none of these haplogroups showed any effect on the pen-
etrance of LHON. Similarly, frequencies of haplogroups
M7b102, G, and M8a are not signiﬁcantly increased in
LHON pedigrees despite their apparent background effect
on the penetrance. The exact reason for this apparentJournal of Human Genetics 83, 760–768, December 12, 2008 765
inconsistency remains unclear and this pattern is in con-
trast to the European study,7 in which an internal consis-
tency of the haplogroup association was observed,
namely, haplogroup J is present at an increased frequency
in LHON families with m.11778G/A and m.14484T/C,
and subdivisions of this haplogroup have increased pene-
trance. Analysis of the complete mtDNA sequences of
LHON probands with M7b102 and G status did not iden-
tify the two speciﬁc combinations of cytochrome b amino
acid changes that are responsible for the background ef-
fect of haplogroups J1c and J2b in the penetrance of
LHON in western European patients,21 suggesting differ-
ent mtDNA mutation spectra and mechanisms in the
penetrance of LHON in the East and the West. The in-
creased risk of LHON penetrance of haplogroup M7b102
may be due to the coexistence of m.11778G/A and
m.12811T/C, whereas the effect of haplogroup G as
a risk factor in the disease expression may be related to
the nonsynonymous mutation m.4833A/G in the MT-
ND2 gene. The haplogroup-speciﬁc combination of two
amino acid changes A20T and T53I in the MT-ATP6
protein may be the cause for a beneﬁcial background ef-
fect of M8a. The identiﬁcation of haplogroup background
in LHON expression in Chinese families will undoubtedly
help to understand the pathogenesis of LHON and guide
future genetic counseling.
Supplemental Data
Supplemental Data include two tables and can be found with this
paper online at http://www.ajhg.org/.
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